• Pharmaceutical companies are backing away from a growing threat that could kill 10 million people a year by 2050

    3 monthes ago - By Business Insider

    Novartis in July became the latest pharmaceutical company to shut down its antibiotics research projects.
    The move comes as FDA commissioner Scott Gottlieb has expressed concern over the growing epidemic around antimicrobial resistance, which is when bacteria grow resistant to available medications.
    New options to combat the resistant bacteria include antibiotic-combination therapy and bacteriophage therapy.
    Just two years after Novartis announced it would embrace the challenge of searching for cures for life-threatening infections known as superbugs, the drugmaker said last week it would...
    Read more ...

     

  • 15 companies express interest in $61 million Georgia State University project

    15 companies express interest in $61 million Georgia State University project

    3 monthes ago - By Biz Journals

    The state-of-the-art, 200,000-square-foot Convocation Center will be on the corner of Fulton Street and Capitol Avenue and have an 8,000-seat arena.
    Read more ...